Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D01TBL
|
|||
Former ID |
DIB003004
|
|||
Drug Name |
HRGP
|
|||
Synonyms |
Angiogenesis inhibitor, Innoventus; HRGP (solid tumor); HRGP (solid tumor), Innoventus Project; Histidine-Rich glycoprotein (solid tumor), Innoventus Project
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199, 210-229] | Investigative | [1] | |
Company |
Innoventus Project AB
|
|||
Structure |
Download2D MOL |
|||
Formula |
C12H9N3O
|
|||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CC3=CN=CN3)C(=O)N2
|
|||
InChI |
1S/C12H9N3O/c16-12-10(5-8-6-13-7-14-8)9-3-1-2-4-11(9)15-12/h1-7H,(H,13,14)(H,15,16)/b10-5+
|
|||
InChIKey |
VEEGZPWAAPPXRB-BJMVGYQFSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:92147
|
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.